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Periodontitis is a common inflammatory disease
that leads to tooth loss and has been linked to
cardiovascular disease and diabetes mellitus. The
periodontal microbiome is highly diverse, and
metatranscriptomic studies have indicated that the
genes that are expressed by the microbiota are
more relevant than the microbial composition in
the pathogenesis of periodontitis. A recent study of
early metabolic activities in the dysbiotic microbiome
reveals a functional signature that distinguishes
periodontal sites that will become inflamed, supporting
the idea that microbial communities as a whole drive
disease progression.tic microbial community that synergizes to induce chronicThe periodontal microbiome
Periodontitis is a chronic inflammatory disease that com-
promises the supporting tissues of the teeth, collectively
known as the periodontium, and affects nearly 750 million
people worldwide [1]. Periodontitis leads to tooth loss, but
emerging research now links periodontitis to a number of
systemic diseases, including cardiovascular disease, pre-
term delivery and low birth weight, diabetes mellitus,
respiratory infections, and osteoporosis. Given the wide-
ranging effects of periodontal disease, an understanding of
the pathogenic mechanisms that underlie it is crucially
important. The current model of periodontal disease pro-
gression proposes that changes in periodontal microbiota,
or dysbiosis, de-regulate the host immune response, lead-
ing to chronic inflammation. We know little, however,Correspondence: gary.wang@medicine.ufl.edu
1Division of Infectious Diseases and Global Medicine, Department of
Medicine, University of Florida College of Medicine, 1600 SW Archer Road,
Gainesville, FL 32610, USA
2North Florida/South Georgia Veterans Health System, Medical Service, 1601
SW Archer Road, Gainesville, FL 32608, USA
© 2015 Wang; licensee BioMed Central. This is
Attribution License (http://creativecommons.o
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise credited.about the initiating stage of dysbiosis that leads to disease
progression. In Genome Medicine, Yost et al. [2] report
the results of community-wide in situ expression analysis
in the early stages of dysbiosis associated with periodon-
titis progression, providing evidence that the entire dys-
biotic microbiome drives periodontitis pathogenesis.
It has long been appreciated that changes in periodontal
microbiota contribute to periodontitis pathogenesis. A
triad of the so-called ‘red complex’, a group of three oral
anaerobic bacteria, Porphyromonas gingivalis, Treponema
denticola and Tannerella forsythia, has traditionally been
considered to cause periodontitis. More recently, advances
in high-throughput sequencing technology have revolu-
tionized our ability to examine microbial communities,
and it is becoming evident that the real culprit is a dysbio-
inflammation and tissue destruction. The periodontal
microbiota is more diverse than previously thought [3-6],
with over 700 microorganisms identified as possible com-
ponents. Many of these are previously unidentified or
unrecognized organisms, and up to 100 different taxa can
be present at any one site in any given individual [3-5].
This immense diversity of periodontal microbiota, along
with the lack of consistent association between any organ-
ism or group of organisms and periodontitis, suggests that
more organisms need to be considered to delineate fully
the pathogenic mechanisms underlying periodontitis.
These sequence-based findings of a diverse, complex
periodontal microbiota have led to a new model of peri-
odontal pathogenesis, termed ‘polymicrobial synergy and
dysbiosis’ (PSD) [7]. This model proposes that periodon-
titis is initiated by a dysbiotic microbial community, ra-
ther than by select periodontal pathogens, within which
different microbial members or specific gene combina-
tions have distinct roles that synergize to shape a micro-
biota that causes disease. Central to this model is the
concept of a synergistic, dysbiotic microbiota that canan Open Access article distributed under the terms of the Creative Commons
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tion to a chronic inflammatory state. Thus, the whole
microbial community drives disease progression.
Evidence from metatranscriptomics
Two recent metatranscriptomic studies [8,9] have pro-
vided support for the idea that the genes expressed by
the microbiota and their functions are more relevant to
periodontal disease pathogenesis than the actual com-
position of the microbiota. Jorth et al. [9] compared the
metatranscriptome of healthy and diseased periodontal
sites from patients with aggressive periodontitis. Despite
high inter-individual variations in microbial composition,
the metabolic gene expression profiles were highly con-
served among disease-associated microbial communities.
Thus, it appears that there is a high degree of functional
redundancy within disease-associated communities, in
which different microorganisms with conserved metabolic
functions can substitute for each other to cause disease.
In another study, Duran-Pinedo and colleagues [8] com-
pared the subgingival in situ genome-wide transcriptome
of periodontally healthy and diseased individuals. These
investigators found that several functional signatures,
including iron acquisition, lipopolysaccharide synthesis
and flagellar synthesis, were characteristic of periodontitis.
What was surprising was that a large number of virulence
factors that were upregulated in diseased microbiomes
belonged to organisms not traditionally considered to
be periodontal pathogens. In the context of the new
PSD model [7], these data suggest that many previously
unrecognized bacteria might serve as accessory pathogens
that contribute to collectively elevating the virulence of
dysbiotic microbial communities, stimulating chronic in-
flammation and disrupting homeostasis, ultimately leading
to periodontal tissue destruction. Nevertheless, the cross-
sectional design of this study [8] and that of Jorth et al. [9]
makes it difficult to determine whether the changes
in microbiome composition and metabolic function ob-
served are a cause or a consequence of disease.
Early metabolic activities in the dysbiotic
microbiome
In Genome Medicine, Yost et al. [2] describe an import-
ant contribution to our understanding of the early meta-
bolic activities in the dysbiotic microbiome that lead to
periodontal disease progression. Using a combined
metagenomic and metatranscriptomic approach, these
authors analyzed community-wide microbiome genomes
and their gene expression in periodontal sites that pro-
gressed over time, compared to sites that remained clinic-
ally stable. The overall community composition and their
active microbiota were significantly altered in progressive
periodontal sites. The overexpression of genes related to
cell motility, lipid A and peptidoglycan biosynthesis, andthe transport of iron, potassium and amino acids was ob-
served. In addition, several major periodontal pathogens
had upregulated expression of a large number of genes
and putative virulence factors in sites where disease had
progressed compared to the same sites at baseline. By con-
trast, the microbial composition and in situ community-
wide gene expression changed only minimally in clinically
stable sites from the same subjects.
Several functional signatures were characteristic of
progressing sites [2]. At baseline, isoprenoid and polysac-
charide biosynthesis, sulfur compound metabolic processes,
potassium ion transport and protein kinase C-activating
G-protein coupled receptor signaling pathways were
highly expressed. When the sites progressed, defined by a
2 mm or greater increase in clinical attachment loss com-
pared to baseline genes associated with pathogenesis, re-
sponse to oxidative stress, and ferrous iron transport were
highly expressed.
Next, when the authors compared baseline samples
from progressing and non-progressing sites, they detected
notable differences in the overall microbial community
and in the components of the active microbiome. In base-
line sites that developed disease progression, P. gingivalis,
several members of the orange complex, including Prevo-
tella intermedia and Eubacterium nodatum, and species
that were previously underappreciated, including Filifactor
alocis, were found to be more active. Interestingly, the
other two members of the red complex, T. denticola and
T. forsythia, were not significantly more active. An in-
creased expression of genes related to proteolysis, sulfur-
compound metabolism and response to antibiotics was
observed in baseline sites that developed disease progres-
sion. The authors indicated that the high activity of P. gin-
givalis at the baseline of progressing sites supports the
keystone pathogen hypothesis [10], in which the keystone
species (that is, P. gingivalis) can elevate the virulence of
the entire microbial community, by interacting and com-
municating with other members of the microbial commu-
nity to disrupt tissue homeostasis and mediate disease
progression.
Interestingly, in the baseline sites that appeared clinic-
ally healthy, a large fraction of the microbial community
was highly active. This was demonstrated by the overex-
pression of genes related to citrate, organic ion and lac-
tate transport, sulfur compound metabolic processes,
and peptidoglycan catabolism. This finding suggests that
in these individuals with periodontitis, clinically healthy
sites were already impacted by disease.
Functional signatures
By comparing gene expression profiles before and after
the manifestation of clinical disease, Yost et al. [2] were
able to define functional signatures that distinguished
the early metabolic activities occurring at progressing
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citrate transport, iron transport, potassium transport,
amino-acid transport, isoprenoid biosynthesis and ciliary
and flagellar motility. Intriguingly, at baseline, a large num-
ber of putative virulence factors were upregulated in a set
of organisms not typically associated with periodontitis -
Streptococcus oralis, Streptococcus mutans, Streptococcus
intermedius, Streptococcus mitis, Veillonella parvula and
Pseudomonas fluorenscens - some of which are often asso-
ciated with periodontal health. Taken together, the findings
of Yost et al. [2] are consistent with the PSD model [7]
and support the idea that whole dysbiotic microbial com-
munities, initially induced by keystone species such as
P. gingivalis, synergize and drive the progression of
periodontitis.
Emerging data have provided insights into the role of
dysbiotic microbial communities in periodontitis patho-
genesis. Microbial dysbiosis has effects on human physi-
ology that go beyond periodontitis and involve a number
of clinically important processes, such as obesity, colitis,
inflammatory bowel disease, and colorectal cancer. For
example, dysbiotic gut microbiome can lead to a loss of
colonization resistance against enteric pathogens and
subsequently to colitis caused by Clostridium difficile.
While the molecular and cellular mechanisms leading to
microbial dysbiosis remain poorly understood, this study
by Yost et al. [2] represents a major step forward in un-
derstanding the early microbial activities associated with
periodontal disease progression. Importantly, this work
contributes additional support for an increasingly appre-
ciated model of polymicrobial synergy and dysbiosis for
the pathogenesis of periodontitis. It will lead to a more
thorough understanding of this complex disease process,
and ultimately to the development of targeted novel
therapeutics.
Abbreviation
PSD: Polymicrobial synergy and dysbiosis.
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